Healthcare / Health Information ServicesUpdated 2026-05-10 22:07 UTC

SOPH stock hub

SOPHiA GENETICS SA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SOPHis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

369.1M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

SOPH

In the news

Latest news · SOPH

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-123.3

P25 -105.6P50 -46.5P75 -3.1

ROIC-40.3

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SOPH market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

207

Groups with data

Currency

USD

Showing 207 of 207 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001840706
Company name	SOPHiA GENETICS SA
Country	Switzerland
Country code	US
Cusip	H82027105
Employees	415
Employees Change	-8%
Employees Change Percent	-1.89
Enterprise value	$366.1M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Health Information Services
IPO Date	2021-07-23
Isin	CH1125843347
Last refreshed	2026-05-10
Market cap	$369.1M
Market cap category	Small-Cap
Price	$5.15
Price currency	USD
Rev Per Employee	195,614.46x
Sector	Healthcare
Sic	7374
Symbol	SOPH
Website	https://www.sophiagenetics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-21.93%
EV Sales Forward	3.7x
EV/Sales	4.51x
FCF yield	-11.3%
P/B ratio	8.07x
P/S ratio	4.55x
PS Forward	3.73x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-88.91%
EBITDA Margin	-86.18%
Gross margin	67.28%
Gross Profit	$54.6M
Gross Profit Growth	19.41%
Gross Profit Growth Q	20.81%
Gross Profit Growth3 Y	16.84%
Gross Profit Growth5 Y	23.85%
Net Income	$-80.9M
Net Income Growth Years	0%
Pretax Margin	-98.14%
Profit Margin	-99.7%
Profit Per Employee	$-195,027
ROA	-29.71
Roa5y	-22.17
ROCE	-65.38
ROE	-123.3
Roe5y	-56.26
ROIC	-40.31

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	71.73%
Cagr3y	2.16%
EPS Growth Years	0
Revenue Growth	20.85x
Revenue Growth Q	21.99x
Revenue Growth Quarters	6x
Revenue Growth Years	6x
Revenue Growth3 Y	17.02x
Revenue Growth5 Y	22.12x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.53
Assets	$157M
Cash	$65.4M
Current Assets	$95.8M
Current Liabilities	$46.6M
Debt	$62.4M
Debt Equity	$1.37
Equity	$45.7M
Interest Coverage	-12.98
Liabilities	$111.3M
Long Term Assets	$61.2M
Long Term Liabilities	$64.7M
Net Cash	$3M
Net Cash By Market Cap	$0.8
Net Cash Growth	-92.27%
Net Debt Equity	$-0.06
Tangible Book Value	$9.9M
Tangible Book Value Per Share	$0.14
WACC	9.41

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.06
Inventory Turnover	4.38
Net Working Capital	$-13.5M
Quick ratio	1.71
Working Capital	$49.2M
Working Capital Turnover	$1.47

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.41%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	71.67%
200-day SMA	4.44
3Y total return	6.63%
50-day SMA	4.87
50-day SMA vs 200-day SMA	50over200
All Time High	19.8
All Time High Change	-73.99%
All Time High Date	2021-08-31
All Time Low	1.69
All Time Low Change	205.64%
All Time Low Date	2022-11-09
ATR	0.31
Beta	1.01
Beta1y	1.13
Beta2y	1.3
Ch YTD	10.28
High	5.67
High52	5.7
High52 Date	2026-01-22
High52ch	-9.65%
Low	5.1
Low52	2.59
Low52 Date	2025-06-20
Low52ch	98.84%
Ma50ch	5.66%
Premarket Change Percent	0.19
Premarket Price	$5.41
Premarket Volume	307
Price vs 200-day SMA	16.07%
RSI	52.67
RSI Monthly	54.48
RSI Weekly	56.41
Sharpe ratio	1.07x
Sortino ratio	1.88
Total Return	-3.41%
Tr YTD	10.28
Tr1m	5.1%
Tr1w	-3.2%
Tr3m	7.29%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.24
Earnings Revenue Estimate	20,404,250x
Earnings Revenue Estimate Growth	14.77x
Operating Income	$-72.2M
Operating margin	-88.91
Price target	$7.5
Price Target Change	$45.63

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	51,579,601%
Float Percent	71.97%
Net Borrowing	32,585,000
Shares Insiders	10.58%
Shares Institutions	30.91%
Shares Out	71,668,702
Shares Qo Q	4.48%
Shares Yo Y	3.41%
Short Float	0.34%
Short Ratio	1.84
Short Shares	0.25

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-57.4M
Average Volume	100,977.2x
Bv Per Share	0.64
CAPEX	$-1.5M
Ch1m	5.1
Ch1w	-3.2
Ch1y	71.67
Ch3m	7.29
Ch3y	6.63
Ch6m	17.85
Change	-4.63%
Change From Open	-4.98
Close	5.4
Days Gap	0.37
Depreciation Amortization	2,220,000
Dollar Volume	1,056,471
Earnings Date	2026-05-05
Earnings Time	bmo
EBIT	$-72.2M
EBITDA	$-70M
EPS	$-1.18
F Score	2
FCF	$-41.7M
FCF EV Yield	-11.39x
FCF Per Share	$-0.58
Financing CF	44,209,000
Fiscal Year End	December
Founded	2,011
Income Tax	$1.3M
Investing CF	-10,212,000
Ipr	-71.39
Iprfo	-72.09
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-03
Ma150	4.76
Ma150ch	8.17%
Ma20	5.1
Ma20ch	0.92%
Net CF	-3,136,000
Next Earnings Date	2026-08-04
Open	5.42
Optionable	Yes
Position In Range	8.77
Post Close	5.15
Postmarket Change Percent	-0.39
Postmarket Price	$5.13
Ppne	16,797,000
Pre Close	5.4
Price Date	2026-05-08
Ptbv Ratio	37.42
Relative Volume	2.03x
Revenue	81,180,000x
SBC By Revenue	19.32x
Share Based Comp	15,683,000
Tax By Revenue	1.55x
Tr6m	17.85%
Volume	205,140

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does SOPH pay a dividend?

Capital-return profile for this ticker.

Performance

SOPH stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SOPH?

Insider, institutional, and short-interest positioning.

Institutional ownership

+30.9%

Float: +72.0% of shares outstanding

Insider ownership

+10.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

SOPH momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

52.7

Neutral momentum band

Price vs 200-day MA

+16.1%

50/200-day relationship not available

Beta (5Y)

1.01

Moves roughly with the market

Sharpe ratio

1.07

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SOPH

Hub-level FAQ points readers to the deeper analysis pages.

What is the current SOPH stock rating?

SOPHiA GENETICS SA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full SOPH analysis?

The full report lives at /stocks/SOPH/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for SOPH?

The latest report frames SOPH around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the SOPH page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.